Mellisa Cotton, who first reported her own Avaira® Toric contact lens problems to eFoodAlert on September 5th, posted the following comment earlier today:

As if this could not get any worse!!! I was one of the first posts regarding a severe corneal abrasion that I went to the ER for on September 4th. I was wearing the Avaira lenses.

Last evening my husband came home and said he must have pink eye. He’d taken out his lenses earlier because his vision was hazy. His eye were both totally red and hurt–he said he felt like he had sand in both eyes. I said it didn’t look like pink eye but he was hurting and went to bed. This morning the eyes were bad so he went to the doctor. She told him both eyes were very swollen and irritated and prescribed steroid drops. I was unaware until this afternoon that he had been wearing a new pair of lenses for the last week. They are COOPERVISION PROCLEAR MULTIFOCAL. I understand these are not recalled yet. Please, can you get the word out?

Mellisa Cotton

Atlanta, GA

CooperVision acknowledged this morning in a news release that it had received some reports of “severe eye pain” associated with its recalled Avaira® Toric contact lenses. But the problems experienced by wearers of the company’s lenses extend far beyond the Avaira® brand.

In addition to the brands identified in public recall notices around the world – Avaira®, Encore100®, BioComfort XO and Lent Soft 4 Air Tórica – consumers are reporting eye irritation and injuries as a result of wearing CooperVision ProClear, Frequency55, and UltraFlex55 contact lenses.

ProClear and Frequency55 are CooperVision brands. The UltraFlex brand belongs to Ocular Sciences, Inc. As I reported on October 3rd, John Fruth, the founder and former Chairman of Ocular Sciences, was President of CooperVision’s contact lens division before he founded Ocular Sciences. And the mailing address of one of Ocular Sciences’ manufacturing locations is right around the corner from CooperVision Manufacturing Ltd.’s UK production facility in Eastleigh, England.

How much longer will consumers be kept in the dark about the magnitude of this contact lens safety issue?